Quarterly report · Q1
4078.TEDINET S100RJIK
Period2023-04-01 → 2023-06-30
Filed2023-08-07
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 32
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥21.1bn | 2023-04-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥83.9bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥21.4bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Operating income | ¥932m | 2023-04-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | ¥1.8bn | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | ¥926m | 2023-04-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥4.6bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.1bn | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥878m | 2023-04-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥2.6bn | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥454m | 2023-04-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.3bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.8bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥565m | 2023-04-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | ¥1.8bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥131.4bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥128.0bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥127.2bn | at 2022-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥45.9bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥43.3bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥85.5bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥84.7bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥84.0bn | at 2022-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥14.8bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥12.4bn | at 2023-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥28.04 | 2023-04-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥144.85 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥109.4 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥27.64 | 2023-04-01 → 2023-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 61.7% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.9% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.9% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-06-30 | −¥302m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-06-30 | −¥302m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-06-30 | −¥569m |
| jpcrp040300-q1r_E00780-000Chemicalreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥19.3bn |
| jpcrp040300-q1r_E00780-000Chemicalreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥19.1bn |
| jpcrp040300-q1r_E00780-000Chemicalreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥247m |
| jpcrp040300-q1r_E00780-000Chemicalreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥1.4bn |
| jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥2.0bn |
| jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥2.0bn |
| jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥54m |
| jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥60m |
| —segment total | revenue | 2023-04-01 → 2023-06-30 | ¥21.4bn |
| —segment total | revenue external | 2023-04-01 → 2023-06-30 | ¥21.1bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥302m |
| —segment total | segment profit | 2023-04-01 → 2023-06-30 | ¥1.5bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥435m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥435m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥558m |
| jpcrp040300-q1r_E00780-000Chemicalreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥19.8bn |
| jpcrp040300-q1r_E00780-000Chemicalreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥19.5bn |
| jpcrp040300-q1r_E00780-000Chemicalreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥360m |
| jpcrp040300-q1r_E00780-000Chemicalreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥2.3bn |
| jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥2.0bn |
| jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥1.9bn |
| jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥74m |
| jpcrp040300-q1r_E00780-000Medicine And Health Carereportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥89m |
| —segment total | revenue | 2022-04-01 → 2022-06-30 | ¥21.8bn |
| —segment total | revenue external | 2022-04-01 → 2022-06-30 | ¥21.4bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥435m |
| —segment total | segment profit | 2022-04-01 → 2022-06-30 | ¥2.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 367
| Item | Context | Value | Unit |
|---|---|---|---|
| Extraordinary income | Prior1YTDDuration | 453000000 | JPY |
| Extraordinary income | CurrentYTDDuration | 42000000 | JPY |
| Loss on retirement of noncurrent assets el | Prior1YTDDuration | 5000000 | JPY |
| Loss on retirement of noncurrent assets el | CurrentYTDDuration | 91000000 | JPY |
| Extraordinary loss | Prior1YTDDuration | 5000000 | JPY |
| Extraordinary loss | CurrentYTDDuration | 91000000 | JPY |
| Income before income taxes | Prior1YTDDuration | 2573000000 | JPY |
| Income before income taxes | CurrentYTDDuration | 878000000 | JPY |
| Income taxes | Prior1YTDDuration | 734000000 | JPY |
| Income taxes | CurrentYTDDuration | 313000000 | JPY |
| Profit loss | Prior1YTDDuration | 1838000000 | JPY |
| Profit loss | CurrentYTDDuration | 565000000 | JPY |
| Profit loss attributable to non controlling interests | Prior1YTDDuration | 69000000 | JPY |
| Profit loss attributable to non controlling interests | CurrentYTDDuration | 110000000 | JPY |
| Profit loss attributable to owners of parent | Prior1YTDDuration | 1769000000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | 454000000 | JPY |
| Profit loss | Prior1YTDDuration | 1838000000 | JPY |
| Profit loss | CurrentYTDDuration | 565000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YTDDuration | -271000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYTDDuration | 500000000 | JPY |
| Deferred gains or losses on hedges net of tax oci | Prior1YTDDuration | 39000000 | JPY |
| Deferred gains or losses on hedges net of tax oci | CurrentYTDDuration | 89000000 | JPY |
| Foreign currency translation adjustment net of tax oci | Prior1YTDDuration | 326000000 | JPY |
| Foreign currency translation adjustment net of tax oci | CurrentYTDDuration | 88000000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | Prior1YTDDuration | -0 | JPY |
| Remeasurements of defined benefit plans net of tax oci | CurrentYTDDuration | -4000000 | JPY |
| Other comprehensive income | Prior1YTDDuration | 95000000 | JPY |
| Other comprehensive income | CurrentYTDDuration | 674000000 | JPY |
| Comprehensive income | Prior1YTDDuration | 1933000000 | JPY |
| Comprehensive income | CurrentYTDDuration | 1239000000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 1777000000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 1099000000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | 156000000 | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | 139000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E00780-000ChemicalReportableSegmentsMember | 19455000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E00780-000MedicineAndHealthCareReportableSegmentsMember | 1945000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 21400000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 21400000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E00780-000ChemicalReportableSegmentsMember | 360000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E00780-000MedicineAndHealthCareReportableSegmentsMember | 74000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | 435000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -435000000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E00780-000ChemicalReportableSegmentsMember | 19816000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E00780-000MedicineAndHealthCareReportableSegmentsMember | 2019000000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 21835000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -435000000 | JPY |
| Net sales | Prior1YTDDuration | 21400000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E00780-000ChemicalReportableSegmentsMember | 2295000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |